MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Russian Bear who wrote (695)	2/18/1998 6:46:00 PM
From: seminole	Read Replies (1) of 1826

Mr Bear <<<I wouldn't be in MOGN without Salagen, that much is certain. I imagine others feel the same>>> Not everyone feels exactly the same way. I wouldn't be in MOGN without MGI 114. If this company was just about Salagen, I would have stayed with MRK. However with Salagen covering my backside, I was able to load up for the Phase II show that will begin shortly. Acylfulvenes must be in my blood, apparently they are soluble in ice water. richard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next